Coya Therapeutics

Graphic image of puzzle pieces missing from a persons brain a symbol of degeneration andor the improvement of it
Biotech

Coya shares data on IL-2 prospect in small Alzheimer's study

Coya put the asset on the back burner last year but said the data boost its confidence in pursuing partnerships and studying drug combinations.
Nick Paul Taylor Oct 29, 2024 7:55am
Paragliding over the cliffs Fort Funston San Francisco

BioMarin builds exec team with biotech vets—Chutes & Ladders

Aug 23, 2024 8:30am
cash runway cash airplane extend deal earnings

Coya taps familiar friend Dr. Reddy's to commercialize ALS med

Dec 6, 2023 11:20am
airplane divert change block no reject direction oath

Coya deems dementia drug R&D plan 'premature,' switches focus

Jun 12, 2023 9:00am
Photo of a ballerina striking a pose at the center of the stage while the crowd watches

Few biotechs dare to test 'eerie' Wall Street IPO market

May 8, 2023 6:00am
money time

Coya debuts in final moment of 2022 with $15M IPO

Jan 3, 2023 11:05am